Presentation is loading. Please wait.

Presentation is loading. Please wait.

Charles L. Loprinzi, MD, Steven R. Alberts, MD, Bradley J

Similar presentations


Presentation on theme: "Charles L. Loprinzi, MD, Steven R. Alberts, MD, Bradley J"— Presentation transcript:

1 History of the Development of Antiemetic Guidelines at Mayo Clinic Rochester 
Charles L. Loprinzi, MD, Steven R. Alberts, MD, Bradley J. Christensen, BS Pharm, Lorelei J. Hanson, RN, David R. Farley, MD, Joan K. Broers, RN, Donna L. Betcher, RN, Robert E. Grady, MD, Peter A. Southorn, MD, Todd M. Johnson, PharmD, Edith A. Perez, MD  Mayo Clinic Proceedings  Volume 75, Issue 3, Pages (March 2000) DOI: / Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions

2 Figure 1 Mean episodes of emesis per person per day for patients receiving grade 3 emetogenic chemotherapy (left) or grade 4 emetogenic chemotherapy (right). Patients with 5 or more episodes of emesis per day were classified as having 5 emesis episodes for that day. Mayo Clinic Proceedings  , DOI: ( / ) Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions

3 Figure 2 Percentage of patients with complete emesis control (no emetogenic episodes) per day for those receiving grade 3 emetogenic chemotherapy (left) or grade 4 emetogenic chemotherapy (right). Mayo Clinic Proceedings  , DOI: ( / ) Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Charles L. Loprinzi, MD, Steven R. Alberts, MD, Bradley J"

Similar presentations


Ads by Google